Shah Nikita
Executive Vice President
Shah Nikita has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Shah Nikita is listed as Executive Vice President at Amneal Pharmaceuticals, Inc. Inside the rolling window, Shah Nikita reported no open-market purchases and 2 open-market sales totaling $4.1M in AMRX. The largest disclosed transaction in the window is a sale of 146,403 AMRX shares on Aug 12, 2026, worth $2.6M.
Companies traded
Other insiders at AMRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shah Nikita made?
Shah Nikita has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Shah Nikita trade?
Shah Nikita has filed SEC Form 4 disclosures for 1 company, including AMRX.
When was Shah Nikita's most recent SEC Form 4 filing?
Shah Nikita's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Shah Nikita's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shah Nikita is listed as Executive Vice President.
What is Shah Nikita's total buy and sell value in the current window?
Inside the rolling retention window, Shah Nikita bought $0 and sold $4.1M based on SEC Form 4 filings.
What was Shah Nikita's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 146,403 AMRX shares on 2026-08-12, worth $2.6M, per SEC Form 4 filings.